Health Technology

Kobayashi Pharmaceutical Co., Ltd.

In the news

Kobayashi Pharma ramps up output of popular cooling gel Mar 23, 2019
Tourists to Japan now spending more on the cheap Aug 29, 2017
Market Scramble: Search is on for adept acquirers Apr 12, 2017
Market Scramble: Foreigners seek buying opportunities in downturn Apr 7, 2017
'Foundations' ruffle foreign investors Mar 26, 2017

See more articles on Kobayashi Pharmaceutical Co., Ltd.

Business Summary

Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, air fresheners, and sanitary products. It operates through the following segments: Domestic, International, Mail Order, and Others. The Domestic segment manufactures and sells health care products, daily necessities, skin care products, and body warmers in Japan. The International segment sells beauty and health care products overseas. The Mail Order segment offers nutritional supplements and skin care products online. The Others segment includes transportation, synthetic resin container, advertising planning and production, insurance agency, and real estate businesses. The company was founded by Chubei Kobayashi in February 1886 and is headquartered in Osaka, Japan.

Financial Highlights

Dec 2021	JPY	USD
Revenue	155,252M	1,413.01M
Gross Profit	86,379M	786.16M
Operating income	25,846M	235.23M
Income before tax	27,636M	251.52M
Net income	19,715M	179.43M
EBITDA	30,681M	279.24M
Diluted EPS	252.35	2.29
Dividends Per Share	83	0.75
Total Assets	252,554M	2,193.16M
Total liabilities	56,952M	494.56M
Total equity	195,600M	1,698.58M
Operating cash flow	22,419M	204.04M
	Currency in JPY	Currency in USD

Historical Data

JPY | USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021
Revenue	156,761M	167,479M	158,340M	150,514M	155,252M
Gross Profit	94,189M	101,963M	89,689M	84,125M	86,379M
Operating income	22,809M	26,191M	25,512M	25,809M	25,846M
Income before tax	22,572M	25,304M	26,804M	26,635M	27,636M
Net income	15,863M	18,023M	19,139M	19,205M	19,715M
EBITDA	26,328M	29,594M	29,639M	29,915M	30,681M
Diluted EPS	201.02	227.95	244.07	245.70	252.35
Dividends Per Share	58	66	73	77	83
Total Assets	218,831M	228,787M	233,732M	238,366M	252,554M
Total liabilities	65,016M	62,536M	61,072M	55,781M	56,952M
Total equity	153,811M	166,249M	172,657M	182,583M	195,600M
Operating cash flow	22,350M	20,007M	20,089M	23,986M	22,419M

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021
Revenue	1,397.98M	1,516.43M	1,452.51M	1,409.72M	1,413.01M
Gross Profit	839.97M	923.21M	822.75M	787.91M	786.16M
Operating income	203.40M	237.14M	234.03M	241.72M	235.23M
Income before tax	201.29M	229.11M	245.88M	249.46M	251.52M
Net income	141.46M	163.18M	175.56M	179.87M	179.43M
EBITDA	234.79M	267.95M	271.89M	280.18M	279.24M
Diluted EPS	1.79	2.06	2.23	2.30	2.29
Dividends Per Share	0.51	0.59	0.66	0.72	0.75
Total Assets	1,942.57M	2,085.28M	2,150.74M	2,308.74M	2,193.16M
Total liabilities	577.15M	569.98M	561.96M	540.27M	494.56M
Total equity	1,365.38M	1,515.28M	1,588.74M	1,768.44M	1,698.58M
Operating cash flow	199.31M	181.15M	184.28M	224.65M	204.04M

Valuation Measures

Dec 2021
PER	35.82
ROA	8.03%
ROE	10.42%
Operating margin	16.64%
Profit margin	12.69%

Key executives

President & Representative Director: Akihiro Kobayashi
Manager-Finance & Accounting: Noriaki Hirao
Executive Officer & General Manager-Manufacturing: Tetsuji Nishioka
Executive Officer & Manager-Healthcare Business: Fujito Owaki
Executive Officer & Manager-Mail Order Sales: Yoshihiro Ogawa

Shareholders

KOBAYASHI AKIHIRO /KOBAYASHI PHARMACEUTICAL/ (11.8%)
Kobayashi Foundation (7.6%)
WATANABE IKUKO (3.1%)
MFS International (UK) Ltd. (3.1%)
Ohtori Ltd. (2.7%)
MIYATA FAMILY /KOBAYASHI PHARMACEUTICAL/ (2.6%)
Kobayashi Pharmaceutical Co., Ltd. (2.6%)
Nomura Asset Management Co., Ltd. (2.4%)
IUE YUKAKO (2.3%)
The Vanguard Group, Inc. (2.0%)

Contact Details

Website:http://www.kobayashi.co.jp
Address: KDX Kobayashi Doshomachi Building, 4-4-10 Dosho-machi, Osaka, 541-0045, Japan
Phone: +81.6.6231.1144

Related Companies

Kobayashi Pharmaceutical Global E-Commerce Co. Ltd.
Kobayashi Pharmaceutical Value Support Co., Ltd.
Kiribai Kobayashi Pharmaceutical Co., Ltd.
Kobayashi Pharmaceutical Logistics Co. Ltd.
Kobayashi Healthcare International, Inc.
Jiangsu Kobayashi Pharmaceutical Co. Ltd.
True Nature Co. Ltd.
Kobayashi Pharmaceutical Aoitori Foundation
Kobayashi America Manufacturing LLC
Hefei Kobayashi Daily Chemicals Co. Ltd.
PT Kobayashi Pharmaceutical Indonesia
Kobayashi Healthcare LLC
Kobayashi Healthcare (Malaysia) Sdn. Bhd.
Kobayashi Pharmaceutical (Taiwan) Co. Ltd.
Kobayashi Healthcare of America, Inc.
Shanghai Kobayashi Pharmaceutical Business Co. Ltd.
Hefei Kobayashi Daily Products Co. Ltd.
Kobayashi Healthcare (Thailand) Co., Ltd.
PT Kobayashi Eglin
KOBAYASHI Pharmaceutical (Singapore) Pte Ltd.
Kobayashi Pharmaceutical (Hong Kong) Co., Ltd.
Kobayashi Healthcare Australia Pty Ltd.
Kobayashi Healthcare Europe Ltd.
Rokuyou-Seiyaku, Inc.
Kobayashi Medical America LLC
Archer Corp. (Japan)
Meitan Hompo Co. Ltd.
Kobayashi Pharmaceutical Business Association
Ehime Kobayashi Pharmaceutical Co. Ltd.
Kobayashi Pharmaceutical Distribution Co. Ltd.

Competitors

Last Updated on 3 Feb, 2023